Iovance Biotherapeutics (NASDAQ: IOVA) 報告稱，季度每股虧損$(0.26)，好於分析師一致預期的$(0.27)，增幅爲3.7%。 這比去年同期的$(0.45)每股虧損增加了42.22%。 公司報告的季度銷售額爲$7370萬，好於分析師一致預期的$7239.3萬，增幅爲1.81%。 這比去年同期的$482.000千銷售額增加了15.19千百分比。

以上內容來自Benzinga Earnings專欄，原文如下：

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 42.22 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $73.700 million which beat the analyst consensus estimate of $72.393 million by 1.81 percent. This is a 15.19K percent increase over sales of $482.000 thousand the same period last year.